Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study (Q37036991)
Jump to navigation
Jump to search
scientific article published on 16 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study |
scientific article published on 16 April 2013 |
Statements
1 reference
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study (English)
1 reference
Beatriz Grinsztejn
1 reference
Anne F Luetkemeyer
1 reference
Diane V Havlir
1 reference
Susan Swindells
1 reference
Prudence Ive
1 reference
Susan L Rosenkranz
1 reference
Darlene Lu
1 reference
Florence Marzan
1 reference
Evelyn Hogg
1 reference
Constance A Benson
1 reference
Ian M Sanne
1 reference
Francesca Aweeka
1 reference
Adult AIDS Clinical Trials Group A5221 Study Team
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference